G. Baker Hubbard

ORCID: 0000-0001-5427-438X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Ocular Oncology and Treatments
  • Retinopathy of Prematurity Studies
  • Retinal and Macular Surgery
  • Glaucoma and retinal disorders
  • Intraocular Surgery and Lenses
  • Retinal and Optic Conditions
  • Ocular Diseases and Behçet’s Syndrome
  • Retinal Imaging and Analysis
  • Neonatal Respiratory Health Research
  • Ocular Infections and Treatments
  • Cancer-related Molecular Pathways
  • Neonatal Health and Biochemistry
  • Neonatal and fetal brain pathology
  • Child Abuse and Related Trauma
  • Ocular Disorders and Treatments
  • Retinal Development and Disorders
  • Vascular Malformations Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Nonmelanoma Skin Cancer Studies
  • Corneal Surgery and Treatments
  • Drug-Induced Ocular Toxicity
  • Corneal surgery and disorders
  • Ocular Surface and Contact Lens
  • Systemic Lupus Erythematosus Research

Emory Eye Center
2016-2025

Emory University
2016-2025

Mayo Hospital
2024

L V Prasad Eye Institute
2024

Foundation Fighting Blindness
2020

Research to Prevent Blindness
2007-2015

Texas Biomedical Research Institute
2000-2009

Molecular Oncology (United States)
2009

Prevent Blindness
2009

Theragenics Corporation (United States)
2007-2008

The Centers for Disease Control and Prevention developed screening diagnostic testing guidelines chlamydia gonorrhea at urethral, rectal, pharyngeal sites men who have sex with (MSM). However, in most clinical settings, rectal chlamydial is not performed MSM, primarily sexually transmitted disease (STD) clinics alone perform routine asymptomatic men.We evaluated the prevalence of gonococcal infections among MSM seen municipal STD clinic gay men's community health center. We also determined...

10.1086/430704 article EN Clinical Infectious Diseases 2005-06-02
Wei Chen Dwight Stambolian Albert O. Edwards Kari Branham Mohammad Othman and 95 more Jóhanna Jakobsdóttir Nirubol Tosakulwong Margaret A. Pericak‐Vance Peter A. Campochiaro Michael L. Klein Perciliz L. Tan Yvette P. Conley Atsuhiro Kanda Laura J. Kopplin Yanming Li Katherine J. Augustaitis Athanasios J. Karoukis William K. Scott Anita Agarwal Jaclyn L. Kovach Stephen G. Schwartz Eric A. Postel Matthew Brooks Keith H. Baratz William L. Brown Alexander J. Brucker Anton Orlin Gary C. Brown Allen C. Ho Carl D. Regillo Larry A. Donoso Lifeng Tian Brian Kaderli Dexter Hadley Stephanie A. Hagstrom Neal S. Peachey Ronald Klein Barbara E.K. Klein Norimoto Gotoh Kenji Yamashiro Frederick L. Ferris Jesen Fagerness Robyn Reynolds Lindsay A. Farrer Ivana K. Kim Joan W. Miller Marta Cortón Ángel Carracedo Manuel Sánchez‐Salorio Elizabeth Pugh Kimberly F. Doheny Marı́a Brión Margaret M. DeAngelis Daniel E. Weeks Donald J. Zack Emily Y. Chew John R. Heckenlively Nagahisa Yoshimura Sudha K. Iyengar Peter J. Francis Nicholas Katsanis Johanna M. Seddon Jonathan L. Haines Michael B. Gorin Gonçalo R. Abecasis Anand Swaroop Robert N. Johnson Everett Ai H. Richard McDonald Margaret Stolarczuk Peter R. Pavan Karina K. Billiris Mohan Iyer Matthew M. Menosky Scott E. Pautler Sharon M. Millard G. Baker Hubbard Thomas Aaberg Lindy DuBois Alice T. Lyon Susan Anderson-Nelson Lee M. Jampol David V. Weinberg Annie Muñana Zuzanna Rozenbajgier David H. Orth Jack Cohen Matthew MacCumber Matthew MacCumber Celeste Figliulo Liz Porcz James C. Folk H. Culver Boldt Stephen R. Russell Rachel Ivins Connie J. Hinz Charles C. Barr Steve Bloom Ken Jaegers Brian Kritchman

We executed a genome-wide association scan for age-related macular degeneration (AMD) in 2,157 cases and 1,150 controls. Our results validate AMD susceptibility loci near CFH ( P < 10 −75 ), ARMS2 −59 C2/CFB −20 C3 −9 CFI −6 ). compared our top findings with the Tufts/Massachusetts General Hospital study of advanced (821 cases, 1,709 controls) genotyped 30 promising markers additional individuals (up to 7,749 4,625 controls). With these data, we identified locus TIMP3 (overall = 1.1 × −11...

10.1073/pnas.0912702107 article EN Proceedings of the National Academy of Sciences 2010-04-12

PurposeTo evaluate the efficacy of a single intravitreal injection rAAV2/2-ND4 in subjects with visual loss from Leber hereditary optic neuropathy (LHON).DesignRESCUE is multicenter, randomized, double-masked, sham-controlled, phase 3 clinical trial.ParticipantsSubjects m.11778G>A mitochondrial DNA mutation and vision ≤6 months onset 1 or both eyes were included.MethodsEach subject’s right eye was randomly assigned (1:1) to treatment (single 9 × 1010 viral genomes 90 μl) sham injection. The...

10.1016/j.ophtha.2020.12.012 article EN cc-by-nc-nd Ophthalmology 2021-01-13

A unique pigmentary maculopathy was recently described in 6 patients with long-term exposure to pentosan polysulfate sodium (PPS), a long-standing oral therapy for interstitial cystitis.To characterize the characteristics and clinical manifestations of PPS-associated maculopathy.In this multi-institutional case series, medical records who exhibited characteristic setting prior PPS were retrospectively reviewed. Data collected from August 1, 2012, October 2018, data analyzed 2018 January...

10.1001/jamaophthalmol.2019.3392 article EN JAMA Ophthalmology 2019-09-05

Measurable competence derived from comprehensive and advanced training in grading digital images is critical studies using a reading center to evaluate retinal fundus infants at risk for retinopathy of prematurity (ROP). Details certification nonphysician trained readers (TRs) have not yet been described.To describe centralized system ROP by TRs the Telemedicine Approaches Evaluating Acute-Phase Retinopathy Prematurity (e-ROP) Study.Multicenter observational cohort study conducted July 1,...

10.1001/jamaophthalmol.2015.0460 article EN JAMA Ophthalmology 2015-03-27

Age-related changes in the skeleton often lead to an increase susceptibility of bone fracture. The purpose this study was determine whether differences material properties between osteonal and interstitial regions have effect on fracture properties. Parameters such as longitudinal toughness, transverse porosity, microhardness, density, weight fractions mineral organic phases were examined a function age using female baboon femurs. With increasing age, toughness decreased significantly did...

10.1002/1097-4636(20000915)51:4<735::aid-jbm23>3.0.co;2-g article EN Journal of Biomedical Materials Research 2000-01-01

Retinoblastoma (RB) is most often diagnosed with clinical features and not tumor biopsy. This study describes tumor-derived analyte concentrations from aqueous humor (AH) liquid biopsy its use in assays.Case series study.Sixty-two RB eyes 55 children 14 control 12 4 medical centers.This included 128 AH samples including: diagnostic (DX) samples, undergoing treatment (TX), after completing (END), during bevacizumab injection for radiation therapy (BEV). Fourteen-control were analyzed...

10.1016/j.xops.2023.100289 article EN cc-by-nc-nd Ophthalmology Science 2023-02-20

The purpose of this study was to explore the relationship between integrity collagen and biomechanical properties bone. In study, age (range, 5-26 years old) gender related changes in cortical bone samples from 33 baboon femurs (15 males 18 females) were examined. percentage denatured determined using a selective digestion technique. fracture toughness, elastic modulus, yield ultimate strength, energy three-point bending configurations. porosity weight fractions mineral organic phase also...

10.1097/00003086-200002000-00027 article EN Clinical Orthopaedics and Related Research 2000-02-01

In Brief Purpose: To evaluate the safety and effect of bevacizumab pretreatment on incidence recurrent vitreous hemorrhage visual acuity after vitrectomy for proliferative diabetic retinopathy. Methods: This was a consecutive, retrospective, comparative cohort study. Patients undergoing from September 2006 through November 2007 at Emory Eye Center complications retinopathy were identified reviewed. A total 33 eyes pretreated with 104 untreated observed postoperative final acuity. Results: in...

10.1097/iae.0b013e3181a8eb88 article EN Retina 2009-07-01

<h3>Objective</h3> To compare the efficacy of intravitreal bevacizumab plus ablative therapy with alone for Coats' disease. <h3>Methods</h3> A retrospective review all paediatric patients who received treatment disease from a single surgeon (GBH) 1 January 2001 to 31 March 2010 was performed. Ten consecutive as part their were matched 10 treated by macular appearance, quadrants subretinal fluid, and telangiectasias. Outcomes evaluated number sessions, time full treatment, resolution...

10.1136/bjophthalmol-2012-302250 article EN British Journal of Ophthalmology 2012-12-25
Sharon F. Freedman Amra Hercinovic David K. Wallace Raymond T. Kraker Zhuokai Li and 95 more Amit Bhatt Charline S. Boente Eric R. Crouch G. Baker Hubbard David L. Rogers Deborah K. VanderVeen Michael B. Yang Nathan L. Cheung Susan A. Cotter Jonathan M. Holmes Sharon F. Freedman S. Grace Prakalapakorn David K. Wallace Sarah K. Jones Navajyoti R. Barman Robert J. House David A. Nasrazadani Eric R. Crouch Earl R. Crouch Gaylord G. Ventura Michael B. Yang Eniolami O. Dosunmu Michael E. Gray William W. Motley Katherine Castleberry Patricia Cobb Patricia Hirsch Melissa Reed Monica A. Sandoval Neil Vallabh David L. Rogers Don L. Bremer Richard P. Golden Catherine O. Jordan Mary Lou McGregor Rachel E. Reem Amanda N. Schreckengost Sara A. Maletic Rachel Tobe Miller Amit Bhatt David K. Coats Gihan Romany Ann B. Demmy Lingkun Kong M. Elizabeth Hartnett David C. Dries Robert O. Hoffman Susan Allman Katie Jo Farnsworth Barbara Hart Kelliann Ordonez Amy K. Hutchinson George Baker Hubbard Prethy Rao Joshua Robinson Judy Brower Kathryn M. Haider Charline S. Boente Heather Smith Elizabeth Hynes Michele E. Whitaker Deborah K. VanderVeen Jason S. Mantagos Carolyn Wu Samantha Goldstein Tamar Winter Grace X. Yoon R. Michael Siatkowski Janine E. Collinge Kelli J. Satnes Michelle H. Blunt Michael X. Repka Courtney L. Kraus Jennifer Shepard Raymond T. Kraker Roy W. Beck Darrell S. Austin Nicole M. Boyle Danielle L. Chandler Patricia L. Connelly Courtney L. Conner Quayleen Donahue Brooke P. Fimbel Robert J. Henderson Amra Hercinovic James E. Hoepner Joseph D. Kaplon Zhuokai Li Michele Melia Gillaine Ortiz Julianne L. Robinson Kathleen M. Stutz Desirae R. Sutherland David O. Toro Victoria C. Woodard

10.1016/j.ophtha.2022.05.019 article EN publisher-specific-oa Ophthalmology 2022-06-01
Coming Soon ...